FDA Approves Voquezna for Erosive Esophagitis, GERD
Phase 3 trial showed noninferiority versus lansoprazole in healing and maintenance phases
American College of Gastroenterology, Oct. 20-25
Antireflux Mucosal Ablation Safe, Effective for Refractory Reflux Disease
A number of patients undergoing the endoscopic treatment may experience significant reductions in GERD symptoms
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
Findings seen for inflammatory bowel disease overall, as well as individual diseases
Critics Slam Updated Infection Control Recommendations for Hospitals
Health care workers worry whether the guidelines are protecting a hospital's bottom line rather than worker health
Hep C Testing Recommendations Developed for Perinatally Exposed Infants
Four recommendations include HCV testing of all perinatally exposed infants with nucleic acid testing for HCV RNA at age 2 to 6 months
High-Powered Magnet Ingestion Still Sending Children to Hospital
Some disparities seen in injury, treatment, and outcomes based on neighborhood opportunity scores
Thalidomide Cuts Recurrent Bleeding in Small-Intestinal Angiodysplasia
More patients receiving thalidomide 100 mg, 50 mg had effective response than those receiving placebo
FDA Approves Wezlana for Multiple Inflammatory Diseases
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
Interventions to Redesign Patient Care Do Not Improve Outcomes
Nurses reported improvement in median teamwork climate score, but no improvement in hospitalized patient outcomes
